Search

Your search keyword '"Migaud P"' showing total 91 results

Search Constraints

Start Over You searched for: Author "Migaud P" Remove constraint Author: "Migaud P" Search Limiters Available in Library Collection Remove constraint Search Limiters: Available in Library Collection
91 results on '"Migaud P"'

Search Results

1. Incontinentia pigmenti underlies thymic dysplasia, autoantibodies to type I IFNs, and viral diseases.

2. Neutralizing IFN-γ autoantibodies are rare and pathogenic in HLA-DRB1*15:02 or 16:02 individuals.

Catalog

Books, media, physical & digital resources

3. Synthesis, Detection, and Metabolism of Pyridone Ribosides, Products of NAD Overoxidation.

4. Role of IL-27 in Epstein–Barr virus infection revealed by IL-27RA deficiency

6. Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency

7. Genetic inhibition of CARD9 accelerates the development of atherosclerosis in mice through CD36 dependent-defective autophagy

8. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

9. Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1

10. Dominant-negative mutations in human IL6ST underlie hyper-IgE syndrome.

13. Genetic, immunological, and clinical features of patients with bacterial and fungal infections due to inherited IL-17RA deficiency

14. SLC25A51 is a mammalian mitochondrial NAD+ transporter

16. A specific inhibitor of ALDH1A3 regulates retinoic acid biosynthesis in glioma stem cells

27. Nicotinamide Adenine Dinucleotide in Aging Biology: Potential Applications and Many Unknowns

39. Effects of long-term low-salinity on haemolymph osmolality, gill structure and transcriptome in mud crab (Scylla paramamosain)

40. Correction: Dominant-negative mutations in human IL6ST underlie hyper-IgE syndrome.

41. A reduced form of nicotinamide riboside defines a new path for NAD+ biosynthesis and acts as an orally bioavailable NAD+ precursor.

42. Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children

43. Nicotinamide riboside kinases display redundancy in mediating nicotinamide mononucleotide and nicotinamide riboside metabolism in skeletal muscle cells.

45. Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice.

46. Loss of NAD Homeostasis Leads to Progressive and Reversible Degeneration of Skeletal Muscle.

47. Infectious diseases, autoimmunity and midline defect in a patient with a novel bi-allelic mutation in IL12RB1 gene.

48. NAD precursors cycle between host tissues and the gut microbiome.

50. Human TYK2 deficiency: Mycobacterial and viral infections without hyper-IgE syndrome